Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neu...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 6; p. e0157160
Main Authors Edén, Arvid, Marcotte, Thomas D., Heaton, Robert K., Nilsson, Staffan, Zetterberg, Henrik, Fuchs, Dietmar, Franklin, Donald, Price, Richard W., Grant, Igor, Letendre, Scott L., Gisslén, Magnus
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 13.06.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.
AbstractList Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). Design and Methods We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Results Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Conclusions Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.
Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.
OBJECTIVEAlthough milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART).DESIGN AND METHODSWe selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions.RESULTSGeometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06).CONCLUSIONSMild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.
Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). Design and Methods We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Results Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Conclusions Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.
Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.
Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.
Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p
Audience Academic
Author Nilsson, Staffan
Marcotte, Thomas D.
Price, Richard W.
Letendre, Scott L.
Gisslén, Magnus
Heaton, Robert K.
Fuchs, Dietmar
Zetterberg, Henrik
Franklin, Donald
Edén, Arvid
Grant, Igor
AuthorAffiliation 4 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
5 Institute of Neurology, University College London, London, United Kingdom
7 Department of Neurology, University of California San Francisco, San Francisco, California, United States of America
1 Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
UNSW Australia, AUSTRALIA
2 Department of Psychiatry, University of California San Diego, San Diego, California, United States of America
3 Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden
6 Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria
AuthorAffiliation_xml – name: 7 Department of Neurology, University of California San Francisco, San Francisco, California, United States of America
– name: 1 Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
– name: 2 Department of Psychiatry, University of California San Diego, San Diego, California, United States of America
– name: 3 Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden
– name: 6 Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria
– name: 5 Institute of Neurology, University College London, London, United Kingdom
– name: UNSW Australia, AUSTRALIA
– name: 4 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Author_xml – sequence: 1
  givenname: Arvid
  surname: Edén
  fullname: Edén, Arvid
– sequence: 2
  givenname: Thomas D.
  surname: Marcotte
  fullname: Marcotte, Thomas D.
– sequence: 3
  givenname: Robert K.
  surname: Heaton
  fullname: Heaton, Robert K.
– sequence: 4
  givenname: Staffan
  surname: Nilsson
  fullname: Nilsson, Staffan
– sequence: 5
  givenname: Henrik
  surname: Zetterberg
  fullname: Zetterberg, Henrik
– sequence: 6
  givenname: Dietmar
  surname: Fuchs
  fullname: Fuchs, Dietmar
– sequence: 7
  givenname: Donald
  surname: Franklin
  fullname: Franklin, Donald
– sequence: 8
  givenname: Richard W.
  surname: Price
  fullname: Price, Richard W.
– sequence: 9
  givenname: Igor
  surname: Grant
  fullname: Grant, Igor
– sequence: 10
  givenname: Scott L.
  surname: Letendre
  fullname: Letendre, Scott L.
– sequence: 11
  givenname: Magnus
  surname: Gisslén
  fullname: Gisslén, Magnus
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27295036$$D View this record in MEDLINE/PubMed
https://gup.ub.gu.se/publication/240034$$DView record from Swedish Publication Index
https://research.chalmers.se/publication/240034$$DView record from Swedish Publication Index
BookMark eNqNk91r1TAYxoso7kP_A9GCIHpxjknTJI0XwhjqDgwnTncb0vRtm9E2NUk399-b7pzJzpgf9KLt29_z0Dwvz17ycLADJMkzjJaYcPz23E5uUN1yjOMlwpRjhh4ku1iQbMEyRB7eet5J9rw_R4iSgrHHyU7GM0ERYbtJWA3agfJQpashOBVa0KpLV30_DZAe6GAuVDB2SM2Qnhmnuu4qPZ3G0YGfNUerswWOyhp0iK9fIgtD8OmlCW36GSZntW0GE10geo7KuD5-f5I8qlXn4enmvp98__jh2-HR4vjk0-rw4HihCyLCAipeYw24pIpwqDKGgSCmFVGaMo11iRVVHIlaZFmldYTzLNe6LgsOuqY12U9erH3Hznq5CcxLzAXLckoEj8RqTVRWncvRmV65K2mVkdcD6xqpXDC6A8kZIITLCghjea2EYERTrsqKiqJmDEWv07WXv4RxKrfcYlygnG6lblXXg_PSg8RCYSbqQmKMuMxVzmVRaSyLoswJAlzEUXRd_NG1mUYZR800u2U5QmTm32_OPJU9VBrmrXZbsu0vg2llYy9kLhBlnEWD1xsDZ39M4IPsjdfQdWoAO8X0ClSwgmYE_xvlgmeUUDKH8_IOev86NlSjYuJmqG38RT2byoOcUoRJzkSklvdQ8aqgNzrWoTZxviV4syWITICfoVGT93J1-vX_2ZOzbfbVLbYF1YXW226aC-O3wee3l_J7Gzc9jMC7NaCd9d5BLbUJ18WLRzOdxEjOpb8JTc6ll5vSR3F-R3zj_1fZL1wCXCk
CitedBy_id crossref_primary_10_1080_14737159_2017_1341313
crossref_primary_10_1186_s12974_019_1404_9
crossref_primary_10_1093_cid_ciad265
crossref_primary_10_1007_s13365_016_0495_7
crossref_primary_10_1021_jasms_3c00276
crossref_primary_10_1007_s13365_020_00877_6
crossref_primary_10_1093_infdis_jix662
crossref_primary_10_1007_s13365_023_01116_4
crossref_primary_10_1128_spectrum_01975_21
crossref_primary_10_3389_fimmu_2020_583934
crossref_primary_10_3390_v14091997
crossref_primary_10_1097_QAD_0000000000002300
crossref_primary_10_1097_QAD_0000000000002980
crossref_primary_10_1007_s13365_018_0696_3
crossref_primary_10_1097_QAD_0000000000002264
crossref_primary_10_3389_fmicb_2018_03352
crossref_primary_10_1097_COH_0000000000000433
crossref_primary_10_1097_QAD_0000000000002270
crossref_primary_10_1128_mBio_00602_20
crossref_primary_10_3390_ijms232113328
crossref_primary_10_1007_s13365_019_00735_0
crossref_primary_10_1093_ofid_ofad064
crossref_primary_10_1007_s11908_017_0606_5
crossref_primary_10_3390_v15020378
crossref_primary_10_1172_jci_insight_121718
crossref_primary_10_3390_ijms17101639
crossref_primary_10_1111_joim_13594
crossref_primary_10_1007_s11904_019_00420_1
crossref_primary_10_1097_QAI_0000000000002714
crossref_primary_10_3390_v15122410
crossref_primary_10_1007_s11904_021_00581_y
crossref_primary_10_1007_s13365_018_0661_1
crossref_primary_10_1136_bmjopen_2022_070693
crossref_primary_10_1093_jac_dkaa473
crossref_primary_10_1097_QAD_0000000000002076
crossref_primary_10_1007_s13365_021_01047_y
crossref_primary_10_1186_s12974_019_1617_y
crossref_primary_10_1097_WCO_0000000000000807
crossref_primary_10_3390_life14040508
crossref_primary_10_1007_s11011_019_00452_x
crossref_primary_10_1212_NXI_0000000000000512
crossref_primary_10_1007_s12035_018_1329_9
crossref_primary_10_3390_v15030700
crossref_primary_10_1016_j_ebiom_2019_10_029
crossref_primary_10_1093_infdis_jiac138
crossref_primary_10_1371_journal_pone_0250987
crossref_primary_10_1093_infdis_jiae555
crossref_primary_10_1038_s41582_023_00813_2
crossref_primary_10_1128_mBio_00591_19
crossref_primary_10_1080_1040841X_2022_2146481
crossref_primary_10_1093_cid_cix473
crossref_primary_10_1097_QAD_0000000000002326
crossref_primary_10_1016_j_jneuroim_2020_577246
crossref_primary_10_1093_infdis_jiac370
crossref_primary_10_1097_QAD_0000000000001950
crossref_primary_10_1097_QAD_0000000000002121
crossref_primary_10_1007_s13365_024_01200_3
crossref_primary_10_1080_13554794_2018_1530362
crossref_primary_10_1016_j_jneuroim_2021_577649
crossref_primary_10_1016_j_phrs_2023_106898
crossref_primary_10_1038_s41582_023_00879_y
crossref_primary_10_1097_MD_0000000000009969
crossref_primary_10_1007_s40265_016_0678_9
crossref_primary_10_1093_infdis_jiz030
crossref_primary_10_3390_brainsci8100190
crossref_primary_10_1002_glia_23568
crossref_primary_10_1093_infdis_jiz031
crossref_primary_10_1016_S2352_3018_20_30107_7
crossref_primary_10_1002_cti2_1318
crossref_primary_10_1093_infdis_jiaa765
crossref_primary_10_1007_s11904_018_0412_1
crossref_primary_10_1016_j_ebiom_2022_103917
crossref_primary_10_1093_cid_cix645
crossref_primary_10_1097_QAD_0000000000002925
crossref_primary_10_1016_S2055_6640_20_30236_3
crossref_primary_10_1172_JCI127413
crossref_primary_10_1371_journal_ppat_1006538
crossref_primary_10_1007_s41999_018_0145_0
crossref_primary_10_1007_s00415_017_8503_2
crossref_primary_10_1002_jcla_23673
crossref_primary_10_1007_s11481_023_10086_7
crossref_primary_10_1172_jci_insight_160267
crossref_primary_10_1111_hiv_13411
crossref_primary_10_3389_fnagi_2019_00187
crossref_primary_10_1097_QAD_0000000000002251
crossref_primary_10_3851_IMP3140
crossref_primary_10_1007_s11904_018_0375_2
crossref_primary_10_1097_MD_0000000000020516
Cites_doi 10.1371/journal.pone.0046178
10.1093/cid/ciq041
10.1097/QAD.0b013e3283354a7b
10.1212/01.wnl.0000278457.55877.eb
10.1007/s00415-012-6688-y
10.1007/BF00180282
10.1093/infdis/174.2.294
10.1007/s11481-006-9035-1
10.1016/S0006-8993(03)03219-0
10.1097/QAI.0b013e31815ace97
10.1046/j.1471-4159.1996.67052013.x
10.1212/01.wnl.0000277635.05973.55
10.1097/QAI.0000000000000458
10.1186/1742-6405-7-15
10.1212/WNL.52.5.1090
10.1186/1471-2334-11-356
10.1212/WNL.0000000000000492
10.1212/WNL.0b013e318200d727
10.1371/journal.pone.0088591
10.1080/13803395.2010.535504
10.1212/01.WNL.0000287431.88658.8b
10.1097/QAD.0000000000000400
10.1086/523648
10.1007/s13365-011-0021-x
10.1080/13803390490510031
10.1371/journal.pone.0116081
10.1186/1742-2094-10-62
10.1080/13854046.2012.694479
10.1186/1741-7015-9-138
ContentType Journal Article
Copyright COPYRIGHT 2016 Public Library of Science
2016 Edén et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2016 Edén et al 2016 Edén et al
Copyright_xml – notice: COPYRIGHT 2016 Public Library of Science
– notice: 2016 Edén et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2016 Edén et al 2016 Edén et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
AAOVB
ADTPV
AOWAS
D8T
F1U
ZZAVC
ABBSD
F1S
DOA
DOI 10.1371/journal.pone.0157160
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
SWEPUB Göteborgs universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Göteborgs universitet
SwePub Articles full text
SWEPUB Chalmers tekniska högskola full text
SWEPUB Chalmers tekniska högskola
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Agricultural Science Database




Virology and AIDS Abstracts




Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Increased Immune Activation in HIV-1 Patients with HAND
EISSN 1932-6203
EndPage e0157160
ExternalDocumentID 1796245397
oai_doaj_org_article_76e001bde3664fa9963c57abd598f660
oai_research_chalmers_se_19a169f8_1107_4a47_8dc1_88b430e184a4
oai_gup_ub_gu_se_240034
PMC4905676
4088094871
A455013469
27295036
10_1371_journal_pone_0157160
Genre Journal Article
GeographicLocations United States
San Francisco California
Sweden
California
United States--US
GeographicLocations_xml – name: United States
– name: San Francisco California
– name: California
– name: United States--US
– name: Sweden
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: R01 NS094067
– fundername: NIMH NIH HHS
  grantid: K24 MH097673
– fundername: NIMH NIH HHS
  grantid: HHSN271201000036C
– fundername: NIMH NIH HHS
  grantid: P30 MH062512
– fundername: NIMH NIH HHS
  grantid: U24 MH100928
– fundername: NIDA NIH HHS
  grantid: P50 DA026306
– fundername: NIMH NIH HHS
  grantid: R01 MH107345
– fundername: NIMH NIH HHS
  grantid: N01 MH022005
– fundername: ;
– fundername: ;
  grantid: ALFGBG-430271
– fundername: ;
  grantid: 2013-2546
– fundername: ;
  grantid: K2011-58P-20931-01-4
– fundername: ;
  grantid: ALFGBG-441051
– fundername: ;
  grantid: N01 MH22005
– fundername: ;
  grantid: K2010-63P-21562-01-4
– fundername: ;
  grantid: U24 MH100928
– fundername: ;
  grantid: K2011-61X-20401-05-6
– fundername: ;
  grantid: P30 MH62512
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
PJZUB
PPXIY
PQGLB
RIG
BBORY
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
5PM
AAOVB
ADTPV
AOWAS
D8T
F1U
ZZAVC
ABBSD
F1S
PUEGO
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c839t-ed7f1ce1b5a37ed261e306ca3ac56c1cb1a5a709f922dcc7f1424ccfb87ecf5f3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Fri Nov 26 17:13:06 EST 2021
Wed Aug 27 01:19:11 EDT 2025
Thu Aug 21 06:57:47 EDT 2025
Thu Aug 21 06:38:54 EDT 2025
Thu Aug 21 18:10:00 EDT 2025
Fri Jul 11 05:35:04 EDT 2025
Thu Jul 10 17:41:24 EDT 2025
Fri Jul 25 10:23:19 EDT 2025
Tue Jun 17 20:58:03 EDT 2025
Tue Jun 10 20:27:33 EDT 2025
Fri Jun 27 03:30:41 EDT 2025
Fri Jun 27 04:57:30 EDT 2025
Thu May 22 21:22:04 EDT 2025
Mon Jul 21 06:03:59 EDT 2025
Tue Jul 01 02:21:18 EDT 2025
Thu Apr 24 23:08:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c839t-ed7f1ce1b5a37ed261e306ca3ac56c1cb1a5a709f922dcc7f1424ccfb87ecf5f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have read the journal's policy and have the following competing interests. AE reports receiving travel grants from Gilead and BMS, and lecture honoraria from AbbVie. MG reports receiving honoraria as speaker and/or advisor from AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Janssen-Cilag, and Merck. HZ is co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Holding-based platform company at the University of Gothenburg. Funds to support research projects have been paid to UC San Diego on behalf of SLL by Abbvie, Gilead Sciences, Merck & Co., and ViiV Healthcare. Honoraria have also been paid to SLL for educational lectures (Abbvie, Janssen) or advisory boards (Cipla, Janssen, Merck & Co., and ViiV Healthcare). RWP reports receiving honoraria as speaker and/or advisor from Gilead, Merck. All other authors declare no conflict of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: MG RWP. Performed the experiments: D. Fuchs HZ. Analyzed the data: AE MG SN. Wrote the paper: AE TDM RKH SN HZ D. Fuchs D. Franklin RWP IG SLL MG. Designed, performed, and coordinated the parent study (CHARTER) as well as the substudy (the NIMH AIDS Research Center (ARC) Biomarker project): IG RKH SLL TDM D. Franklin. Reviewed and identified the cases for the project: SLL TDM D. Franklin.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0157160
PMID 27295036
PQID 1796245397
PQPubID 1436336
ParticipantIDs plos_journals_1796245397
doaj_primary_oai_doaj_org_article_76e001bde3664fa9963c57abd598f660
swepub_primary_oai_research_chalmers_se_19a169f8_1107_4a47_8dc1_88b430e184a4
swepub_primary_oai_gup_ub_gu_se_240034
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4905676
proquest_miscellaneous_1808685231
proquest_miscellaneous_1797253530
proquest_journals_1796245397
gale_infotracmisc_A455013469
gale_infotracacademiconefile_A455013469
gale_incontextgauss_ISR_A455013469
gale_incontextgauss_IOV_A455013469
gale_healthsolutions_A455013469
pubmed_primary_27295036
crossref_citationtrail_10_1371_journal_pone_0157160
crossref_primary_10_1371_journal_pone_0157160
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-06-13
PublicationDateYYYYMMDD 2016-06-13
PublicationDate_xml – month: 06
  year: 2016
  text: 2016-06-13
  day: 13
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2016
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References FR Sattler (ref31) 2015; 68
BJ Brew (ref24) 1996; 174
A Antinori (ref3) 2007; 69
Krut J Jessen (ref12) 2014; 9
LE Rosengren (ref9) 1996; 67
LA Cysique (ref20) 2011; 33
K Blackstone (ref18) 2012; 26
RK Heaton (ref2) 2010; 75
RK Heaton (ref21) 2014
RW Price (ref7) 2007; 69
LE Rosengren (ref10) 1999; 52
A Yilmaz (ref29) 2008; 47
S Simioni (ref4) 2010; 24
BB Gelman (ref25) 2012; 7
C Torti (ref16) 2011; 9
J Peterson (ref27) 2014; 9
A Eden (ref13) 2007; 196
A Mellgren (ref26) 2007; 69
FX Lescure (ref1) 2011; 52
JJ Krut (ref23) 2013; 260
LA Cysique (ref5) 2011; 17
JR Bogner (ref28) 1992; 70
CL Carey (ref19) 2004; 26
L Hagberg (ref22) 2010; 7
M Gisslen (ref6) 2007; 2
A Yilmaz (ref14) 2013; 10
S Abdulle (ref11) 2007
V Dahl (ref30) 2014; 28
N Norgren (ref8) 2003; 987
M Gisslen (ref15) 2011; 11
I Grant (ref17) 2014; 82
References_xml – volume: 7
  start-page: e46178
  issue: 9
  year: 2012
  ident: ref25
  article-title: The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0046178
– volume: 52
  start-page: 235
  issue: 2
  year: 2011
  ident: ref1
  article-title: Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study
  publication-title: Clinical infectious diseases: an official publication of the Infectious Diseases Society of America
  doi: 10.1093/cid/ciq041
– volume: 24
  start-page: 1243
  issue: 9
  year: 2010
  ident: ref4
  article-title: Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
  publication-title: AIDS (London, England)
  doi: 10.1097/QAD.0b013e3283354a7b
– volume: 69
  start-page: 1781
  issue: 18
  year: 2007
  ident: ref7
  article-title: Biomarkers of HIV-1 CNS infection and injury
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000278457.55877.eb
– volume: 260
  start-page: 620
  issue: 2
  year: 2013
  ident: ref23
  article-title: Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections
  publication-title: Journal of neurology
  doi: 10.1007/s00415-012-6688-y
– volume: 70
  start-page: 665
  issue: 8
  year: 1992
  ident: ref28
  article-title: Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection
  publication-title: The Clinical investigator
  doi: 10.1007/BF00180282
– volume: 174
  start-page: 294
  issue: 2
  year: 1996
  ident: ref24
  article-title: Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin
  publication-title: The Journal of infectious diseases
  doi: 10.1093/infdis/174.2.294
– volume: 2
  start-page: 112
  issue: 1
  year: 2007
  ident: ref6
  article-title: Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers
  publication-title: Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology
  doi: 10.1007/s11481-006-9035-1
– volume: 987
  start-page: 25
  issue: 1
  year: 2003
  ident: ref8
  article-title: Elevated neurofilament levels in neurological diseases
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(03)03219-0
– volume: 47
  start-page: 168
  issue: 2
  year: 2008
  ident: ref29
  article-title: Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy
  publication-title: Journal of acquired immune deficiency syndromes (1999)
  doi: 10.1097/QAI.0b013e31815ace97
– volume: 67
  start-page: 2013
  issue: 5
  year: 1996
  ident: ref9
  article-title: Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF
  publication-title: Journal of neurochemistry
  doi: 10.1046/j.1471-4159.1996.67052013.x
– volume: 69
  start-page: 1536
  issue: 15
  year: 2007
  ident: ref26
  article-title: Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000277635.05973.55
– volume: 68
  start-page: 281
  issue: 3
  year: 2015
  ident: ref31
  article-title: Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation
  publication-title: Journal of acquired immune deficiency syndromes (1999)
  doi: 10.1097/QAI.0000000000000458
– volume: 7
  start-page: 15
  year: 2010
  ident: ref22
  article-title: Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
  publication-title: AIDS research and therapy
  doi: 10.1186/1742-6405-7-15
– volume: 52
  start-page: 1090
  issue: 5
  year: 1999
  ident: ref10
  article-title: Neurofilament protein levels in CSF are increased in dementia
  publication-title: Neurology
  doi: 10.1212/WNL.52.5.1090
– volume: 11
  start-page: 356
  year: 2011
  ident: ref15
  article-title: The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
  publication-title: BMC infectious diseases
  doi: 10.1186/1471-2334-11-356
– volume: 82
  start-page: 2055
  issue: 23
  year: 2014
  ident: ref17
  article-title: Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000000492
– volume: 75
  start-page: 2087
  issue: 23
  year: 2010
  ident: ref2
  article-title: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e318200d727
– volume: 9
  start-page: e88591
  issue: 2
  year: 2014
  ident: ref12
  article-title: Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0088591
– volume: 33
  start-page: 505
  issue: 5
  year: 2011
  ident: ref20
  article-title: Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change
  publication-title: Journal of clinical and experimental neuropsychology
  doi: 10.1080/13803395.2010.535504
– volume: 69
  start-page: 1789
  issue: 18
  year: 2007
  ident: ref3
  article-title: Updated research nosology for HIV-associated neurocognitive disorders
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000287431.88658.8b
– volume: 28
  start-page: 2251
  issue: 15
  year: 2014
  ident: ref30
  article-title: Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation
  publication-title: AIDS (London, England)
  doi: 10.1097/QAD.0000000000000400
– volume: 196
  start-page: 1779
  issue: 12
  year: 2007
  ident: ref13
  article-title: Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy
  publication-title: The Journal of infectious diseases
  doi: 10.1086/523648
– volume: 17
  start-page: 176
  issue: 2
  year: 2011
  ident: ref5
  article-title: Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression
  publication-title: Journal of neurovirology
  doi: 10.1007/s13365-011-0021-x
– volume: 26
  start-page: 307
  issue: 3
  year: 2004
  ident: ref19
  article-title: Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection
  publication-title: Journal of clinical and experimental neuropsychology
  doi: 10.1080/13803390490510031
– year: 2014
  ident: ref21
  article-title: Neurocognitive change in the era of HIV combination antiretroviral therapy: A longitudinal CHARTER Study
  publication-title: Clinical infectious diseases: an official publication of the Infectious Diseases Society of America
– volume: 9
  start-page: e116081
  issue: 12
  year: 2014
  ident: ref27
  article-title: Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0116081
– volume: 10
  start-page: 62
  year: 2013
  ident: ref14
  article-title: Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
  publication-title: Journal of neuroinflammation
  doi: 10.1186/1742-2094-10-62
– volume: 26
  start-page: 894
  issue: 6
  year: 2012
  ident: ref18
  article-title: Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings
  publication-title: The Clinical neuropsychologist
  doi: 10.1080/13854046.2012.694479
– year: 2007
  ident: ref11
  article-title: CSF neurofilament protein (NFL)—a marker of active HIV-related neurodegeneration
  publication-title: Journal of neurology
– volume: 9
  start-page: 138
  year: 2011
  ident: ref16
  article-title: Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?
  publication-title: BMC medicine
  doi: 10.1186/1741-7015-9-138
SSID ssj0053866
Score 2.4951446
Snippet Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients...
Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in...
OBJECTIVEAlthough milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in...
ObjectiveAlthough milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in...
Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in...
SourceID plos
doaj
swepub
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0157160
SubjectTerms Acquired immune deficiency syndrome
Activation
Adult
AIDS
AIDS Dementia Complex - cerebrospinal fluid
AIDS Dementia Complex - drug therapy
AIDS Dementia Complex - immunology
Analysis
Anti-Retroviral Agents - therapeutic use
antiretroviral
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Biology and Life Sciences
Biomarkers
Biomarkers - cerebrospinal fluid
Brain research
Care and treatment
Central nervous system
Cerebrospinal fluid
cerebrospinal-fluid neopterin
Cognition
Cognitive ability
Correlation
csf
deficit scores
Dementia
disorders
Dosage and administration
Drug therapy
Drug use
Female
Health aspects
Highly active antiretroviral therapy
HIV
HIV-1 - drug effects
HIV-1 - immunology
hiv-1 infection
Human immunodeficiency virus
Human immunodeficiency virus 1
Humans
Immune response
Impairment
Infections
Infectious diseases
Infectious Medicine
Infektionsmedicin
Lentivirus
Longitudinal Studies
Male
Medicine and Health Sciences
Middle Aged
Neopterin
Neopterin - cerebrospinal fluid
Neopterin - immunology
neurofilament protein
Neurofilament Proteins - cerebrospinal fluid
Neurofilament Proteins - immunology
Neurology
Neuropsychology
Patients
prevalence
Psychiatry
Retroviridae
Social Sciences
Studies
Therapy
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZQT1wQy2sDCwSEeByyG8fPHAti1SJeArbam-XYTlupSqtNe-DfM5OkEREVy4Fj7RlLmRmPZ9yZz4S8kCEXuhAaIjddJDyjPLE5DYnzcBo4ASewx97hT5_l5IJ_uBSXvz31hTVhLTxwK7gzJQN40sIHJiUvLYTnzAllCy9yXUrZZOtw5u2TqdYHwy6WsmuUY4qedXo53ayrcAoHICQJ6eAgavD6e6882qzW9aGQ88_KyQG-aHMmnd8mt7pgMh63H3FEboTqDjnqtmsdv-4wpd_cJVvwA1h-Hnw8xTUh7APlxFPsDgnx2O0fOYuXVTxbAs_qZ4wPfjbQ4j6eTGcJBU6s_YCfX1sw1jrGW9y4wffoy5BgzY1dXuGl4z1ycf7-x7tJ0j24kDiIk7ZJ8KqkLtBCWKYCaIsGyCicZRa05qgrqBVWpXmZZ5l3Doh5xp0rC62CK0XJ7pNRBSI-JnEpQ0hd6i0EUBy0X2hhQy6950Ixm4mIsL30jevQyPFRjJVp_mJTkJW0MjSoM9PpLCJJz7Vp0TiuoX-Liu1pEUu7GQALM52FmessLCJP0SxM25jaewQzxoZwyrjMI_K8oUA8jQoLduZ2V9dm-mX2D0Tfvw2IXnVE5RrE4WzXJAHfhDhdA8qTASV4BTeYPkYj3kulNuB4ZcYFhJ_AuTfsw9PP-mlcFIvwqrDeNTQqE0yw9C80GnJkLSBriMiDdq_00s8gkRMQMUVEDXbRQD3DmWq5aCDPeQ6BugLOl-1-G7DMdxsDQ_OdqYPBmmjGI_LxAGGHn7UwbtE8TlQjA80tlXmpDd6EGG65Mto7arQuOEsD1TD08H_Y0SNyE6JtiXWGlJ2Q0fZqFx5DRLstnjTO6xebkKGy
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELZguXBBLK_tskBAiMchu3X8zAktiNUW8RKwVW-WYzttpSotTXvg3zOTuEERq4Vj7RlLnfG8nPFnQp7LkAtdCA2Zmy5SnlGe2pyG1HmIBk5ABPZ4d_jTZ3l-wT9MxCQeuNWxrXLnExtH7ZcOz8hPYOPIjAsIn29WP1N8NQq_rsYnNK6TGwhdhi1datIVXGDLUsbrckzRk6id49WyCscQBqFUGPbCUYPa3_nmvdViWV-WeP7dP9lDGW0i09ltciumlMlpuwf2ybVQ3SH70Wjr5FVEln59l2zAG2ATevDJCNeE5A9UlIzwjkhITt3uqbNkXiXjOfAsfiX47GcDMO6T89E4pcCJHSDw82sLyVoneJabNCgfXTMSrLmy8zUePd4jF2fvf7w7T-OzC6mDbGmTBq9K6gIthGUqgM5ogLrCWWZBd466glph1TAv8yzzzgExz7hzZaFVcKUo2X2yV4GID0hSyhCGbugtpFEc9kChhQ259J4LxWwmBoTtpG9cxCTHpzEWpvnQpqA2aWVoUGcm6mxA0o5r1WJy_IP-LSq2o0VE7WZguZ6aaKBGyQARu_CBSclLC2Ugc0LZwotclxIXeYLbwrTXUzu_YE7xWjhlXOYD8qyhQFSNCtt2pnZb12b0ZfwfRN-_9YheRqJyCeJwNl6VgP-EaF09yqMeJfgG15s-wE28k0pt_lgRcO429uXTT7tpXBRb8aqw3DY0KhNMsOEVNBoqZS2gdhiQB62tdNLPoJwTkDcNiOpZUU89_ZlqPmuAz3kO6boCzhetvfVYptuVgaHp1tTBYGc04wPy8RLCiKI1M27WPFFUIwPNLZV5qQ2ehxhuuTLaO2q0LjgbBqph6PBqkT0kNyGblthHSNkR2dust-ERZKyb4nHjln4DbLiZdQ
  priority: 102
  providerName: ProQuest
Title Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
URI https://www.ncbi.nlm.nih.gov/pubmed/27295036
https://www.proquest.com/docview/1796245397
https://www.proquest.com/docview/1797253530
https://www.proquest.com/docview/1808685231
https://pubmed.ncbi.nlm.nih.gov/PMC4905676
https://gup.ub.gu.se/publication/240034
https://research.chalmers.se/publication/240034
https://doaj.org/article/76e001bde3664fa9963c57abd598f660
http://dx.doi.org/10.1371/journal.pone.0157160
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG98ILYnytMEpAiI-HTHVsx84DQt20sSI2psGmvlmO43SVqrQ0rcRe-Nu5c9JIEWXwEqnxnaXe-Xx3zvl3hLyOXSJUKhREbioNeUR5aBLqQpuBN7ACPHCGd4dPz-KTS_55JEZbZN2ztRZguTG1w35Sl4vp_s8fNx_B4D_4rg2Srpn257PC7YN7gxQAkvht8E0STfWUN98VwLr910uMWsI46rP6Mt3fZmk5K4_p3-zcnfl0Vm4KS_-srmxhkHq_dXyf3KsDzmBQrZAdsuWKB2SnNukyeFfjTr9_SJawV2CJusuCIc4JoSEoMBjiDRIXDOy6EVowKYKrCfBMbwJsCurhx7PgZHgVUuDE-hD4eV4BtpYBnvQGHgOkKVWCOedmssCDyUfk8vjo--FJWDdlCC3EUsvQZTKn1tFUGCYdaJQ6yDqsYQY0a6lNqRFG9pM8iaLMWiDmEbc2T5V0Nhc5e0w6BYh4lwR57Fzf9jMDQRaHFZIqYVwSZxkXkplIdAlbS1_bGrEcG2dMtf8MJyFzqWSoUWe61lmXhA3XvELs-Af9ASq2oUW8bf9ithjr2ny1jB348zRzLI55biBJZFZIk2YiUXmMk7zAZaGry6vNrqEHeGmcMh4nXfLKUyDmRoFFPWOzKks9_Hr1H0TfLlpEb2uifAbisKa-SAH_CbG8WpR7LUrYOWxreBcX8VoqpYbNOY64gBAVONcLe_Pwy2YYJ8VCvcLNVp5GRoIJ1r-FRkEerQRkFl3ypLKVRvoRJHsCoqoukS0raqmnPVJMrj0sOk8gmJfA-aaytxbLeDXX8Gq80qXTWDfNeJd82UBYY2xda3vtGxiVyEATQ-MkVxpPSzQ3XGqVWaqVSjnrO6rg1dPbhf2M3IVYO8YqQ8r2SGe5WLnnEM8u0x65I0cSnuqQ4vP4U49sHxydnV_0_AlRz29h-Px19Bv6KKcQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3ZbtQw0CrlgSdEubpQqEGcD2nj-EoeECpHtUsPELRV34zjONuVquzS7Ar1p_hGZnKhiKrw0seNZ6zszHgOZw5CnimfyDiVMXhucRqIiInAJswHLgNr4CRY4Axrh_f21fBQfDqWx0vkV1sLg2mVrU6sFHU2dXhHvgmCoyIhwXy-nf0IcGoUfl1tR2jUYrHjz39CyFa-GX0A_j6Pou2PB--HQTNVIHDgDMwDn-mcOc9Sabn28ErMg9vsLLfwao65lFlpdZjkSRRlzgGwiIRzeRpr73KZc9j3GrkOhjfEE6WPuwAPdIdSTXke12yzkYaN2bTwG2B2ITQJe-avmhLQ2YLl2em0vMjR_Ttfs9fVtLKE27fIzcaFpVu1zK2QJV_cJiuNkijpq6aT9es7ZA7aB5PefUZHuCc4myASdIQ1KZ5uuXa0Gp0U9GgCOKfnFMeMVg3NMzocHQUMMDHjBH5-qVvAlhTvjmnVVaRLfoI9Z3Zyhledd8nhlTDkHlkugMSrhObK-9CFmQW3TYDMpbG0PlFZJqTmNpIDwlvqG9f0QMdRHKem-rCnIRaqaWiQZ6bh2YAEHdas7gHyD_h3yNgOFjt4Vw-mZ2PTKASjlQcPIc08V0rkFsJO7qS2aSaTOFe4yTqKhanLYTs9ZLawDJ1xoZIBeVpBYBePAtOExnZRlmb0-eg_gL597QG9bIDyKZDD2aY0A_4TdgfrQa71IEEXud7yKgpxS5XS_Dm1gNkK9sXLT7pl3BRT_wo_XVQwOpJc8vASmBgi81hCrDIg9-uz0lE_gvBRgp82ILp3inrs6a8Uk5Oq0bpIIDzQgPmiPm89lPFiZuDReGFKbzATm4sB2b0AsOnadWLcSTUSqUQEllimkjw2eP9ihBXaxJljJo5TwUPPYnj04HKSrZMbw4O9XbM72t95iPdNYZOZukaW52cL_wi85Xn6uFJRlHy_ap34G8nC2Pg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3ZbtNAcFWChHhBlKuBQg3ifHCb9Z5-QKhQqoaWUlFa9W1Zr9dppMgJdSLUX-PrmPGFLKrCSx_jnVk5M7NzrOcg5Ln0sdCJ0OC56STkEeWhjakPXQrWwAmwwCnWDn_elztH_NOJOFkiv5paGEyrbHRiqajTqcM78g0QHBlxAeZzI6vTIg62tt_NfoQ4QQq_tDbjNCoR2fXnPyF8K94Ot4DXL6Jo--O3DzthPWEgdOAYzEOfqow6TxNhmfLwetSDC-0ss_CajrqEWmHVIM7iKEqdA2AeceeyRCvvMpEx2Pcaua6YoHjG1Ekb7IEekbIu1WOKbtSSsT6b5n4dTDCEKYOOKSwnBrR2oTebTIuLnN6_czc7HU5Lq7h9m9yq3dlgs5K_ZbLk8ztkuVYYRfC67mr95i6ZgybCBHifBkPcExxPEI9giPUpPth0zZi1YJwHx2PAmZwHOHK0bG6eBjvD45ACJmafwM-Dqh1sEeA9clB2GGkToWDPmR2f4bXnPXJ0JQy5T3o5kHiFBJn0fuAGqQUXjoP8JVpYH8s05UIxG4k-YQ31jav7oeNYjokpP_IpiIsqGhrkmal51idhizWr-oH8A_49MraFxW7e5YPp2cjUysEo6cFbSFLPpOSZhRCUOaFskopYZxI3WUOxMFVpbKuTzCaWpFPGZdwnz0oI7OiR49kY2UVRmOGX4_8AOvzaAXpVA2VTIIezdZkG_CfsFNaBXO1Agl5yneUVFOKGKoX5c4IBsxHsi5eftsu4KaYB5n66KGFUJJhgg0tgNETpWkDc0icPqrPSUj-CUFKAz9YnqnOKOuzpruTj07LpOo8hVFCA-bI6bx2U0WJm4NFoYQpvMCub8T7ZuwCw7uB1atxpOR6pQAQaWyrjTBu8izHccmV06qjROuFs4KmGRw8vJ9kauQHa0OwN93cfkZvg1EtMZ6RslfTmZwv_GBznefKk1FAB-X7VKvE32RPdOA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Intrathecal+Immune+Activation+in+Virally+Suppressed+HIV-1+Infected+Patients+with+Neurocognitive+Impairment&rft.jtitle=PloS+one&rft.au=Ed%C3%A9n%2C+Arvid&rft.au=Marcotte%2C+Thomas+D&rft.au=Heaton%2C+Robert+K&rft.au=Nilsson%2C+Staffan&rft.date=2016-06-13&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=11&rft.issue=6&rft_id=info:doi/10.1371%2Fjournal.pone.0157160&rft.externalDocID=A455013469
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon